Dr. Kenneth Offit, MD, MPH
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Breast Cancer
Studies Ovarian Cancer
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Kenneth Offit, MD, MPH is currently running
Genetic Marker Discovery
for Hereditary Cancer
This study is being done to attempt to identify genetic mutations or other gene-based variations in adults and children who have cancer, or are likely to develop an inherited form of cancer, and potentially reduce their risk for cancer or treat the cancer earlier.
Recruiting1 award N/A5 criteria
Genetic Testing Intervention
for Cancer Risk
The purpose of this study is to examine the impact of new cancer genetic counseling models that aim to increase patient engagement with the genetics team. To do this, the study consists of two trials to evaluate two related interventions. The first trial is the EfFORT Trial, which evaluates a cascade genetic testing intervention. Cascade testing is the process of offering genetic testing to people who are at risk of having inherited a possibly harmful gene change that has been found in their family. The study will look at how often genetic testing occurs when healthcare providers have permission to reach out to family members to recommend genetic testing and to help those who are interested get tested. The study will look at whether this cascade testing intervention is practical and effective. The study would like to see how this approach of healthcare providers reaching out directly to family members compares with the usual approach of patients telling their family members about the recommendation to get genetic testing. The second trial is the STRIVE Trial, which evaluates an intervention designed to help patients who receive an uncertain result from genetic testing (also called a "variant of uncertain significance") stay connected with their genetics care team, and to help patients and their primary care providers stay up-to-date about the meaning of uncertain genetic test results. The study will look at whether an intervention that consists of a study online portal for patients with uncertain genetic test results and their primary care providers will help them to stay up-to-date on the meaning of uncertain genetic test results. The study would like to see how this intervention compares to the usual approach of encouraging patients to re-contact their genetics care team on their own about a year after getting genetic testing."
Recruiting1 award N/A7 criteria
More about Kenneth Offit, MD, MPH
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kenneth Offit, MD, MPH has experience with
- Intervention Arm At-risk Relative/ARR Contacts
- PCR/PCR/LDR Strategy
- Blood
- ORAGENE
- BRCA Gene Testing
Breakdown of trials Kenneth Offit, MD, MPH has run
BRIP1 Gene Mutation
Mismatch Repair Gene
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth Offit, MD, MPH specialize in?
Kenneth Offit, MD, MPH focuses on Breast Cancer and Ovarian Cancer. In particular, much of their work with Breast Cancer has involved treating patients, or patients who are undergoing treatment.
Is Kenneth Offit, MD, MPH currently recruiting for clinical trials?
Yes, Kenneth Offit, MD, MPH is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Kenneth Offit, MD, MPH has studied deeply?
Yes, Kenneth Offit, MD, MPH has studied treatments such as Intervention Arm At-risk Relative/ARR Contacts, PCR/PCR/LDR Strategy, Blood.
What is the best way to schedule an appointment with Kenneth Offit, MD, MPH?
Apply for one of the trials that Kenneth Offit, MD, MPH is conducting.
What is the office address of Kenneth Offit, MD, MPH?
The office of Kenneth Offit, MD, MPH is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10021 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.